News

A Strike With Consequences Beyond the Blast Radius

Global financial markets are entering a more complex phase as macroeconomic stability begins to give way to renewed uncertainty. After years of liquidity-driven expansion, supported by low interest rates and accommodative central bank policies, the underlying conditions that sustained elevated asset prices are gradually …

The rapid evolution of artificial intelligence is redefining competitive dynamics across the technology sector. What began as incremental improvements in recommendation systems has now evolved into a structural transformation driven by generative AI. This shift is not only enhancing user engagement but also fundamentally …

New York — United States equity-index futures indicated a mildly higher to flat start for Monday’s session, as investors attempted to stabilize sentiment after last week’s sharp drawdown and heightened volatility. The early tone was “cautious rebound,” with risk appetite constrained by elevated energy …

Artelo Biosciences (NASDAQ: ARTL)surged after announcing an approximately $11m capital raise through an at-the-market private placement of equity and warrants. The structure also includes the potential to generate a further $20.4m, offering additional financial flexibility.

Rocket Pharmaceuticals (NASDAQ: RCKT)emerged as a key outperformer after announcing US Food and Drug Administration accelerated approval for KRESLADI, a gene therapy targeting pediatric patients with severe leukocyte adhesion deficiency-I. The approval represents a pivotal inflection point for the company’s rare disease franchise. Importantly, …

Denali Therapeutics, Inc. (NASDAQ: DNLI) has achieved a significant regulatory milestone with the accelerated approval of Avlayah by the U.S. Food and Drug Administration. The therapy, known scientifically as tividenofusp alfa-eknm, is approved for the treatment of Hunter syndrome, a rare and progressive genetic …